USPTO serial 79353163
LEAPFROG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 16, 2024
- Examiner
- CORNWELL, ANDREA B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LEAPFROG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700DENVER, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for the prevention and treatment of iron disorders, allergies, skin disorders, immune system related diseases and disorders; Pharmaceuticals preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders in domestic animals; Antibacterial preparations for human absorption and consumption, namely, antibacterial pharmaceuticals, antibacterial spray, antibacterial substance for medical purposes, antibacterial hand lotions; antibiotic preparations; antiviral and anti-infectious preparations, namely, antivirals, pharmaceutical products for the treatment of infectious diseases or viral infections; anti-inflammatory preparations; pharmaceutical preparations for dermatological uses; medicinal preparations for slimming purposes; antiseptics, disinfectants; diagnostic preparations for medical purposes; natural remedies in the nature of preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalance, immune system related diseases and disorders, sleep disorders; herbal tinctures for medical purposes; herbal health preparations and remedies, namely, herbal supplements, remedies in the form of chewable tablets, for boosting energy, boosting immune system, promoting healthy skin; cough remedies, namely, cough syrups, cough lozenges, cough treatment preparations; remedies for colds, namely, preparations for treating colds; pharmaceutical preparations derived from natural substances for remedial purposes, namely, for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nasal sprays for medical purposes, nasal rinse, nasal drops for treatment of allergies, nasal decongestants; allopathic remedies, namely, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; homeopathic remedies, namely, homeopathic supplements, homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genito-urinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; herbal tea preparations for medicinal use; herbal oils being herbal extracts adapted for medical use, herbs for medicinal uses; roots for medicinal purposes; peels for medicinal purposes in the nature of medicated skin care preparations; medicated hair lotions and shampoos; medicated skin care lotions and creams; dietary and nutritional supplements for human beings; mineral nutritional supplements; vitamin supplements; dietetic substances, namely, preparations, chews, tablets adapted for medical use; food for babies and infants; infant formula; dietary fibre for treating constipation, aiding digestion; protein powder dietary supplements; medical plasters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 9, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 19, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 19, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 8, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 20, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 20, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 10, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 10, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 9, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 9, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 26, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 31, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 27, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 20, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |